EGFR and hepatocellular carcinoma: In consistence with our findings, dysregulated miR-7 is recently detected in tumor tissues from HCC patients and functions in suppressing cell growth by targeting Akt/mTOR, a survival signaling pathway downstream of EGFR [44].